
Medvi QUAD Reviews
Medvi's 4-in-1 sublingual performance medication - Rx only, prescribed after an online provider review
Last updated: Aug 30, 2026
Medically reviewed by Francheska Capistrano, RMT, MPH · · How we review
Medically reviewed by Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Medically reviewed on Reviewed · Written by Treatments Hub Research Team
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
QUAD is a credible new entry from an established telehealth brand: the 4-in-1 sublingual formula is genuinely differentiated, and the flow is Rx-only with a licensed provider making the call. The honest caveat is newness: no QUAD-specific reviews exist yet, so you are trusting the brand's record.
Pricing, at least, is transparent - $114/month promotional (regularly $179), consultation included, cancel anytime, and you pay nothing if a provider does not qualify you. A licensed provider decides whether this medication is appropriate for you - the intake questions exist for a reason, especially with two PDE5-class ingredients in one dose.
This review is general information, not medical advice.
QUAD is Medvi's entry into men's performance medicine, and its pitch is the formula: a single sublingual dose that Medvi describes as "4-IN-1 PERFORMANCE," combining sildenafil (the active ingredient in Viagra), tadalafil (the active ingredient in Cialis, which Medvi labels "lasts 36 hours"), apomorphine ("ignites desire," in Medvi's words) and L-citrulline ("rapid flow"). It is Rx-only: you complete an online intake, a licensed provider decides whether the medication is appropriate for you, and it ships fast in discreet packaging.
Pricing is published and straightforward: QUAD starts at $114/month at the current promotional rate (regularly $179 - Medvi frames it as 36% off retail, with bundle discounts beyond that), and the price includes the doctor consultation, free rush shipping and 24/7 medical support, with cancel-anytime terms. Medvi also commits to a clean risk rule: if a provider does not qualify you for the medication, you do not pay.
Key Features
- 4-in-1 formula: sildenafil, tadalafil, apomorphine, L-citrulline (per Medvi)
- Sublingual - no injections, no pills to swallow
- Rx-only: online provider review before any prescription
- From $114/mo promo (reg. $179) - consult included, cancel anytime
- Free rush shipping, discreet packaging; 24/7 medical support
Treatment Options
- QUAD 4-in-1 sublingual performance medication (Rx only)
- Online provider evaluation and follow-up
Pricing
QUAD starts at $114/month at the current promotional rate (regularly $179 - 36% off retail per Medvi), with bundle pricing available. The rate includes the doctor consultation, free rush shipping and 24/7 medical support, billed monthly with cancel-anytime terms.
If a provider does not qualify you, you do not pay. Confirm the current rate at checkout - promos change.
Pros
- One dose combines four ingredients (two of them PDE5-class) - convenient, though combining two PDE5 medications is non-standard and needs provider oversight
- Sublingual format - a real alternative for men who won't do injections or dislike pills
- Discreet, fast shipping and a fully online flow
- If you don't qualify, you don't pay - and plans cancel anytime
Cons
- No QUAD-specific review record yet - the product is new
- $114 is a promotional rate - the regular price is $179/month, so confirm the current rate at checkout
- Combining two PDE5-class ingredients (sildenafil + tadalafil) makes the provider review genuinely important - this is not a product to route around the medical questions on
Who It's Best For
- Men who want a needle-free, sublingual performance option from an established telehealth brand
- Anyone who values a discreet, fully online process over pharmacy visits
- Existing Medvi customers who already trust the brand's service record
Final Verdict
QUAD is a credible new entry from an established telehealth brand: the 4-in-1 sublingual formula is genuinely differentiated, and the flow is Rx-only with a licensed provider making the call. The honest caveat is newness: no QUAD-specific reviews exist yet, so you are trusting the brand's record.
Pricing, at least, is transparent - $114/month promotional (regularly $179), consultation included, cancel anytime, and you pay nothing if a provider does not qualify you. A licensed provider decides whether this medication is appropriate for you - the intake questions exist for a reason, especially with two PDE5-class ingredients in one dose.
This review is general information, not medical advice.
Medvi QUAD Review: FAQs
Is Medvi QUAD legit?
QUAD is Medvi's entry into men's performance medicine, and its pitch is the formula: a single sublingual dose that Medvi describes as "4-IN-1 PERFORMANCE," combining sildenafil (the active ingredient in Viagra), tadalafil (the active ingredient in Cialis, which Medvi labels "lasts 36 hours"), apomorphine ("ignites desire," in Medvi's words) and L-citrulline ("rapid flow"). It is Rx-only: you complete an online intake, a licensed provider decides whether the medication is appropriate for you, and it ships fast in discreet packaging. Pricing is published and straightforward: QUAD starts at $114/month at the current promotional rate (regularly $179 - Medvi frames it as 36% off retail, with bundle discounts beyond that), and the price includes the doctor consultation, free rush shipping and 24/7 medical support, with cancel-anytime terms. Medvi also commits to a clean risk rule: if a provider does not qualify you for the medication, you do not pay.
How much does Medvi QUAD cost?
QUAD starts at $114/month at the current promotional rate (regularly $179 - 36% off retail per Medvi), with bundle pricing available. The rate includes the doctor consultation, free rush shipping and 24/7 medical support, billed monthly with cancel-anytime terms. If a provider does not qualify you, you do not pay. Confirm the current rate at checkout - promos change.
What treatments does Medvi QUAD offer?
Medvi QUAD offers QUAD 4-in-1 sublingual performance medication (Rx only), Online provider evaluation and follow-up.
Who is Medvi QUAD best for?
Medvi QUAD is best for Men who want a needle-free, sublingual performance option from an established telehealth brand; Anyone who values a discreet, fully online process over pharmacy visits; Existing Medvi customers who already trust the brand's service record.
Is Medvi QUAD worth it?
QUAD is a credible new entry from an established telehealth brand: the 4-in-1 sublingual formula is genuinely differentiated, and the flow is Rx-only with a licensed provider making the call. The honest caveat is newness: no QUAD-specific reviews exist yet, so you are trusting the brand's record. Pricing, at least, is transparent - $114/month promotional (regularly $179), consultation included, cancel anytime, and you pay nothing if a provider does not qualify you. A licensed provider decides whether this medication is appropriate for you - the intake questions exist for a reason, especially with two PDE5-class ingredients in one dose. This review is general information, not medical advice.
Not sure if Medvi QUAD is right for you?
Take our free quiz and get a personalized provider recommendation.
Find Your MatchRelated
Guides
Sources & methodology
We built this review of Medvi QUAD from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- Medvi QUAD - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: public Reddit discussions and independent YouTube reviews. We report what these sources say - we never fold them into our own scores.
Medical & regulatory references
- 1.Testosterone Therapy in Men With Hypogonadism - Clinical Practice Guideline - The Endocrine Society, 2018
- 2.FDA class-wide labeling changes for testosterone products (incl. the 2015 safety communication) - U.S. Food & Drug Administration
- 3.Testosterone Levels Test - MedlinePlus, U.S. National Library of Medicine (NIH)
- 4.Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE trial) - New England Journal of Medicine, 2023
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.
Medical disclaimer
This page is general information about testosterone replacement therapy and related treatments, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.
Testosterone is a Schedule III controlled substance in the United States and is prescribed only after blood tests confirm low levels. TRT suppresses natural testosterone and sperm production while you are on it, requires ongoing bloodwork, and is not appropriate for men trying to conceive without a clinician's plan. Any clinic that offers testosterone without labs or a licensed prescriber should be avoided.
Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Testosterone Therapy in Men With Hypogonadism - Clinical Practice Guideline - The Endocrine Society, 2018
- 2.FDA class-wide labeling changes for testosterone products (incl. the 2015 safety communication) - U.S. Food & Drug Administration
- 3.Testosterone Levels Test - MedlinePlus, U.S. National Library of Medicine (NIH)
- 4.Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE trial) - New England Journal of Medicine, 2023
